![Shanghai Kehua Bio-Engineering Co.,Ltd logo](/logos/002022.SZ.webp)
Shanghai Kehua Bio-Engineering Co.,Ltd
SZSE:002022.SZ
Overview | Financials
Company Name | Shanghai Kehua Bio-Engineering Co.,Ltd |
Symbol | 002022.SZ |
Currency | CNY |
Price | 8.46 |
Market Cap | 4,350,960,945 |
Dividend Yield | 0% |
52-week-range | 8.17 - 14.42 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Ming Li |
Website | https://www.skhb.com |
An error occurred while fetching data.
About Shanghai Kehua Bio-Engineering Co.,Ltd
Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic products in China. The company offers HBV, hepatitis B, HCV antibody, alpha fetoprotein quantitative, and fecal occult blood test kits; carcino-embryonic antigen quantitative determination kits; test kits for antibody to treponema pallidum and human immunodeficiency virus, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD